CXS won't go anywhere until trial data from both trials are finalised and handed over to Cephalon.
If the data is not up to scratch then expect the SP to plummet.
If Cephalon like what they see they will take up thier options @ 70c and take the lead over the FDA process with the new dataset. This should result in a rise of the SP.
That's the abridged version...if you do not want to take the risk with the trial data you should sell now.
- Forums
- ASX - By Stock
- cxs going anywhere or what?
CXS won't go anywhere until trial data from both trials are...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CXS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online